Despite efforts to solve its credit woes, Impel Pharmaceuticals is still staring down the barrel of bankruptcy, launching a last-ditch attempt to save itself and search for strategic alternatives, including a potential sale.The Seattle-based company hopes to secure a potential sale of assets, sale of the company or a merger, among other options, by early […]
